$Zomedica Pharmaceuticals Corp.(ZOM)$ a little disappointed with their decision of commercialising truforma earlier than expected. But if the performance of truforma exceeds vet's expectation, there are more room to grow for the stock. Hope that they put their gains to good use and research another useful product in near future